Companies Choosing High Quality Offices In Response To Hybrid Work
Companies are choosing high quality offices to encourage employees to work from the office and be their most productive when there, according to CBRE analysis.
Scorpion Biological Services Picks Kansas For $650M Project
Scorpion Biological Services' new 500,000-square-foot biomanufacturing facility will create 500 jobs in Manhattan, KS.
Google Investing $2.1B In New York City
Google will purchase the St. John’s Terminal in Manhattan, which will serve as the anchor of its new Hudson Square campus.
Netflix Expanding With New Production Hub In New York City
An expanded office space in Manhattan and six sound stages in Brooklyn will create up to $100 million in investments and thousands of jobs within five years.
After a decade-long delay, the nation's most-important infrastructure project—the Gateway Hudson River rail tunnel—finally may be getting underway.
Yodle Expands In New York City; Expects To Create 250 New Jobs
Local online marketing company doubles its office space after moving to new Hudson Yards location.
Florence Manufacturing Announces $7 Million Investment In Manhattan, KS
The company will expand its production capabilities and add capacity to support significant growth in Florence’s core business lines. With the expansion, Florence will employ more than 400 workers in Manhattan.
Tallgrass Announces New $5 Million Brewing Facility In Manhattan, KS
Tallgrass Brewing Company was founded in Manhattan in 2007 and is now distributed in 13 states.
BUSINESS REPORT: Kansas – Agricultural Biotechnology Research Is Growing In Kansas
As biotech continues to expand in the Sunflower State, consumer giants Staples, Starwood and a revived Hostess Bakery also call Kansas home. From the July/August 2013 issue.
BookItOut Expands Global Reach With New NYC Location
BookItOut offers business intelligence, lead generation, and actual-cost used car values from a proprietary database containing over 15 million purchase transactions from the last year.
COVER STORY: Global Biotech Report
As the global financial system continues to mend, venture capital is beginning to flow back into the biotechnology sector. In Europe, the largest biomed players are thriving, while entrepreneurial biotech start-ups gain traction in the U.S. From the March/April 2013 issue.